baber/WOPTO huggingface dataset:
Patent NZ-533731-A (NZ)
Title: The use of substituted N-benzylindol-3-ylglyoxylic acid derivatives having an anti-tumoral effect for treating oncoses
Inventor: GUNTHER ECKHARD
IPC: C07D401/12
Filed: 2000-12-19
Abstract: Substituted N-benzylindol-3-yl-glyoxylic acid derivatives of formula (I) which are suitable for use in the treatment of tumors or oncoses is disclosed, wherein R1, R2, R3, R4 and Z are as defined in the specification. (62) Divided Out of 519977
Patent NZ-540442-A (NZ)
Title: Large-scale electroporation plates, systems, and methods of use
Inventor: GAMELIN ANDRE S
IPC: C12M3/00
Filed: 2003-12-03
Abstract: Described are electroporation plates (2) that comprise a plurality of energizable electroporation wells (4) or chambers arrayed in a solid substrate, wherein at least two of the wells (4) in the plate (2) can be independently energized. Each well (4) contains at least two electroporation electrodes (12, 14) disposed therein, and serves as the vessel in which an individual electroporation reaction can be conducted. Also, described are electroporation systems that use electroporation plates (2) according to the invention, as well as methods of using such electroporation plates (2) and systems, for example, to optimize electroporation conditions.
Patent NZ-541959-A (NZ)
Title: System and method for identifying and locating an acoustic event
Inventor: BAXTER KEVIN C
IPC: G01S5/00
Filed: 2004-01-22
Abstract: A method and system for locating the source of an acoustic event, and a sensor (22, 30) for detecting and providing a time of arrival of an acoustic event produced in the environment, is disclosed. The sensor for detecting and providing a time of arrival of an acoustic event in the environment includes: (a) a microphone acoustically coupled to the environment, such that the microphone provides a signal representative of acoustic waves received at the sensor (22, 30), (b) a microprocessor, where the microprocessor is in electrical communication with the microphone, such that a digital representation of the signal is present in the microprocessor, (c) an absolute time clock in digital communication with the microprocessor such that the microprocessor can obtain synchronized time from the absolute time clock, and (d) a network interface in digital communication with the microprocessor such that the microprocessor can communicate over a computer network, wherein when a predetermined event is received at the microphone, the microprocessor obtains a time of arrival from the absolute time clock and transmits the time of arrival over the communication network.
Patent NZ-542802-A (NZ)
Title: Shapeable intraluminal device and method therefor
Inventor: JOHANSEN JERALD A
IPC: A61B5/00
Filed: 2004-03-31
Abstract: A hollow medical device includes a coil member having a distal end, a proximal end, a plurality of turns extending therebetween, and a lumen extending through the turns. The coil member further includes at least one weld extending from one turn to an adjacent turn. The coil can be plastically deformed by bending the coil member at the weld.
Patent NZ-543388-A (NZ)
Title: Process for producing 1,3-propanediol
Inventor: BANIEL AVRAHAM M
IPC: B01D11/04
Filed: 2004-05-06
Abstract: Disclosed herein are processes for the recovery of 1,3-propanediol from an aqueous feed stream. The process involves contacting an aqueous feed stream that comprises water, 1,3-propanediol, and at least one contaminant with at least one solvent extractant to form a mixture. The mixture is separated into a first phase and a second phase. The second phase comprises a majority of the water from the aqueous feed stream. The first phase comprises solvent extractant and at least some of the 1,3-propanediol that was present in the aqueous feed stream. The weight ratio in the first phase of 1,3-propanediol to any one contaminant present is greater than the weight ratio of 1,3-propanediol to the same contaminant in the aqueous feed stream prior to the aqueous feed stream being contacted with the solvent extractant. The first phase can be removed from the separated second phase in order to recover the 1,3-propanediol.
Patent NZ-546355-A (NZ)
Title: A wave power apparatus comprising a plurality of arms arranged to pivot with a mutual phase shift
Inventor: STEENSTRUP PER RESEN
Filed: 2004-10-14
Abstract: A wave power apparatus includes a plurality of arms, each supported by and mounted on a common shaft about which they rotate, and each of which carries a float (124) at its free end, so that a translational movement of the float caused by a wave results in rotation of the arm. The apparatus comprises power conversion means for converting power transmitted from the wave to the arms into electric power, e.g. a hydraulic system, in which a hydraulic fluid is displaced by the movement of the arms to drive one or more hydraulic motors. The plurality of arms is arranged in a row such that a wave passing the row of arms causes the arms to successively pivot with a mutual phase shift. Thus, an even power output may be achieved, and the need for frequency converters may be reduced or eliminated. Preferably, each arm is connected to a hydraulic cylinder of the hydraulic system, whereby a plurality of arms feed hydraulic medium into the hydraulic motor or motors through common hydraulic conduits.
Patent NZ-550050-A (NZ)
Title: Articulated bone screw
Inventor: NIEDERBERGER ALFRED
IPC: A61B17/86
Filed: 2004-03-26
Abstract: The bone screw (1) has a head (2), a shaft (3) and a longitudinal axis (9). The shaft (3) comprises a proximal section (5) adjacent to the head (2) and a distal section (7) secured to the proximal section (5) by a cardan or cardan-like joint (6), the distal section being suitable for introduction into the bone and being provided with an outer thread (4). The bone screw (1) can be bent in all directions relative to its longitudinal axis, while retaining its axial rigidity and fully transmitting a couple without the need for additional means.
Patent NZ-550269-A (NZ)
Title: Skin conditioning agent containing sphingomyelin
Inventor: KATO KEN
IPC: A23L2/66
Filed: 2005-03-30
Abstract: Disclosed is the use of sphingomyelin for manufacturing a skin beautifier for moisturising and/or decreasing the loss of water from the skin, preventing and/or improving skin roughness, and/or preventing wrinkles; wherein the skin beautifier is orally administered. Also disclosed is a cosmetic method by oral administration of a skin beautifier comprising sphingomylin.
Patent NZ-552130-A (NZ)
Title: Compositions and methods for the treatment of cardiovascular disease
Inventor: DUGGAN KAREN ANNETTE
IPC: A61K38/22
Filed: 2005-06-10
Abstract: Provided is the use of vasoactive intestinal peptide (VIP) and/or one or more active fragment(s) thereof, in the manufacture of a medicament for therapeutic treatment of myocardial fibrosis in a subject.
Patent NZ-592049-A (NZ)
Title: Compositions and methods for the treatment of bowel diseases with granulated mesalamine
Inventor: FORBES WILLIAM
IPC: A01N37/36
Filed: 2009-10-02
Abstract: Disclosed herein is the use of a formulation comprising an effective amount of a granulated mesalamine per day in the preparation of a medicament for the treatment of a subject having a gastrointestinal disorder whereby the subject has failed treatment for a gastrointestinal disorder using mesalamine.
Patent NZ-593828-A (NZ)
Title: Trap for air conditioners
Inventor: GRIFFITHS BRENT ALLAN
IPC: E03C1/294
Filed: 2011-08-30
Abstract: 593828 A sealing trap of ruse in a ducted air conditioner apparatus is disclosed. The trap includes a transparent, re-openable, and optionally replaceable reservoir (107) which when in use holds a quantity of liquid. The trap has a two-piece plastics construction (101 and 107) and provides for simplified maintenance. In use, presence of an the amount of water inside the reservoir sufficient to submerge the termination of the open end of the pipe (112) causes the second chamber (110A) to be sealed from the first chamber (109A) thereby preventing gas or noxious vapours traversing the trap in a direction opposite the direction of flow of the water; without use of mechanical, moving components. Included is also a breather pipe (108).
Patent NZ-599666-A (NZ)
Title: Chaperonin 10 variants
Inventor: HOWARD CHRISTOPHER BRUCE
IPC: C07K14/47
Filed: 2010-10-08
Abstract: Disclosed is an isolated chaperonin 10 (Cpn10) variant polypeptide sharing at least 90% sequence identity with a wild-type Cpn10 polypeptide comprising a sequence as defined herein wherein said polypeptide has increased binding affinitiy for a pathogen-associatred molecular pattern (PAMP) or has increased immunomodulatory function.
Patent NZ-600759-A (NZ)
Title: Use of an oleogel containing triterpene for healing wounds
Inventor: SCHEFFLER ARMIN
IPC: A61K9/00
Filed: 2010-11-24
Abstract: Disclosed is the use of an oleo gel comprising a non-polar liquid and a powder containing triterpene as precursors of oleo gel for healing wounds. Further disclosed is the use of oleogel containing a nonpolar liquid and a triterpene-containing powder as the oleogel-forming agent, in the manufacture of a medicament for healing wounds wherein the triterpene-containing powder includes betulin and lupeol, wherein the joint fraction of betulin and lupeol in the triterpene-containing powder is greater than 80 weight-percent.
Patent NZ-600878-A (NZ)
Title: A cap of spray mineral water bottle and multifunctional spray mineral water bottle
Inventor: CHANG HO CHANG
IPC: B05B1/06
Filed: 2011-01-10
Abstract: 600878 Disclosed is a cap for a spray mineral bottle and a multifunctional spray mineral bottle comprising a cap body (1); a spray means (2) and a water locking means. The cap body (1) and bottle neck are connected by means of liquid-tight fit and an outlet aperture is disposed on the end face of the cap body (1). The spray means (2) comprises an atomizing spool (21), nozzle (22) and at least two water channels (24). The water channels (24) are disposed on the outer wall of the atomizing spool (21). A spray aperture (23) is disposed on the end face of the nozzle (22). The atomizing spool (21) is fitted to the nozzle (22) via interference fit through a cavity of the nozzle (22). The water locking means comprises a fixing part (40) and a movable part (31, 32) which are moulded as one unit. The fixing part (40) is connected to the cap body (1). The movable part (31, 32) rotates relative to the fixing part (40) which achieves the opening and closing of the spray means (2). A cavity (38) is disposed in the movable part (31, 32) and an interference fit exists between the spray means (2) and the cavity (38).
Patent NZ-602802-A (NZ)
Title: Use of cold-stabilized methylated vegetable oils as an agricultural chemical coformulant
Inventor: SWAYZE KAREN
IPC: A01N57/16
Filed: 2011-05-03
Abstract: Provided is a pesticide composition comprising a) from 10 to 90 percent by weight of a methylated vegetable oil having less than 10 percent by weight of saturated fatty acid methyl esters and less than 10 percent by weight offatty acid methyl esters of carbon chain length less than C10; and and b) from about 20 to about 65 percent by weight of one or more pesticides dissolved or dispersed in the methylated vegetable oil. Also provided is a method of using a methylated vegetable oil having less than 10 percent by weight of saturated fatty acid methyl esters and less than 10 percent by weight of fatty acid methyl esters of carbon chain length less than C10 as a carrier for basal bark/cut stump applications or as a dormant spraying oil
Patent NZ-603783-A (NZ)
Title: Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
Inventor: DE TOMMASO VINCENZO
IPC: A61K47/26
Filed: 2011-05-18
Abstract: Disclosed herein is a stable injectable pharmaceutical aqueous solution comprising a pharmaceutical compound and lipoic acid as an antioxidant. A non-limiting list of pharmaceutical compounds useful in the present invention are: paracetamol, fructose 1,6 diphosphate, promethazine, amikacin, dobutamine and diclofenac. The solutions according to the invention preferably comprise a non-ionic surfactant which helps solubilization of lipoic acis. A preferred non-ionic surfactant is glychocolic acid.
Patent NZ-606964-A (NZ)
Title: A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
Inventor: EPSHTEIN OLEG ILIICH
IPC: C07K16/40
Filed: 2011-07-15
Abstract: Disclosed is a pharmaceutical composition for administration to a patient suffering from diabetes and other metabolic disorders, the composition comprises a) a homeopathic activated-potentiated form of an antibody to human insulin receptor, and b) a homeopathic activated-potentiated form of an antibody to endothelial NO-synthase.
Patent NZ-607065-A (NZ)
Title: Hand sanitizer
Inventor: GREEN BRUCE
IPC: B05B11/00
Filed: 2011-09-20
Abstract: 607065 A hand sanitiser (2) intended to provide fast drying times and improved skin feel. The sanitiser has (a) a first part (14) comprising a chlorite solution and contained in a first dispenser (4) whereby it will be dispensed as a spray or jet of liquid; and (b) a second part (16) comprising an acid solution and contained in a second dispenser (6) whereby it will be dispensed as a second spray or jet of liquid. The chlorite and the acid will react to provide chlorine dioxide when the first part (14) is mixed with the second part (16). A mixture (18) of equal quantities of the first part (14) and the second part (16) contains at least 15% alcohol by weight. At least a part of the alcohol comprises 3-methoxy-3-methylbutan-1-ol (MMB).
Patent NZ-610634-A (NZ)
Title: Telescoping strut
Inventor: JACK ADOLINE
IPC: B60G11/14
Filed: 2013-05-14
Abstract: A spring system is disclosed. The spring system (10) that includes two housing members (20, 40) that move relative to one another and a mechanical spring (60) that is connected to both housing members. The system is characterised as being a telescopic strut having at least one helical spring that is connected at least on end to a connector (70) attached to a housing by winding the spring onto a first portion (82) of the connector with a helical groove. Both ends of the spring may also be connected in the same way. An additional spring may also be supplied coaxially within the first spring and connected in the same manner to the connector using a second portion. The spring system embodying the present invention is useful in motor vehicles for easing the opening of closure members such as luggage compartment lids, engine compartment lids, hatchbacks, doors, etc; however, the spring systems can be used in many other applications (e.g., struts, shock absorbers, garage door assemblies, hatch or lid assemblies, etc.).
Patent NZ-616771-A (NZ)
Title: Systems and methods for managing blood donations
Inventor: GOODNOW JAMES E
IPC: G16H10/60
Filed: 2012-04-12
Abstract: Methods and apparatus (106) for collecting blood from patients and managing blood donations are disclosed. One feature is a blood collection device configured to collect blood from a patient and periodically transmit blood collection data from the device to a control system (108). Another feature is a system and method for updating firmware on a plurality of blood collection devices. In one embodiment, a software interface with a blood collection control can be used to specify a blood collection protocol, and the blood collection protocol can be then transmitted to one or more blood collection devices.
Patent NZ-620437-A (NZ)
Title: Box with foldable sidewalls and locking mechanisms with overload protection
Inventor: ORGELDINGER WOLFGANG
IPC: B65D6/18
Filed: 2010-04-14
Abstract: A foldable box comprising a base and respectively two outer walls on the longitudinal sides and on the lateral sides which are arranged in pairs opposite each other and which can collapse in relation to the base. Each outer wall on the longitudinal sides comprises, on at least one lateral side end, a projection (22) which extends, in the unfolded state, in the direction of the outer walls on the lateral sides, the projection outwardly defining the collapsibility of the outer walls on the lateral sides. Each outer wall of the lateral sides comprises a spring-loaded locking mechanism which is arranged on the outer side of the outer wall of the lateral side, which comprises, in the unfolded state, a catch element (100) which can be displaced in a direction (8) perpendicular to the surface of the base, the catch element being in contact with the projection of the outer wall on the longitudinal sides. The projection and/or the catch element comprise contact surfaces (108, 110) which are inclined in relation to the perpendicular direction in the unfolded state in such a manner that the locking mechanism opens counter to the spring-load when an inwardly directed predetermined force acts upon the outer wall on the lateral side. At the protrusion of the longitudinal side walls a locking hook (106) passing in parallel to the longitudinal side walls is arranged, including a first contact surface (112) directed inwards and a second contact surface (114) directed outwards.
Patent NZ-622283-A (NZ)
Title: Pyrazolopyrimidine jak inhibitor compounds and methods
Inventor: MAGNUSON STEVEN R
IPC: C07D487/04
Filed: 2010-07-02
Abstract: Disclosed are pyrazolopyrimidine compounds of formula (I) and methods for their preparation. Specific examples of compounds of Formula (I) include: N-(4-(5-chloro-2-methoxyphenyl)-2-(2-hydroxy-2-methylpropyl)thiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; N-(4-(5-chloro-2-methoxyphenyl)-2-(2-methylprop-1-enyl)thiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; N-(2-bromo-4-(5-chloro-2-methoxyphenyl)thiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; N-(4-(5-chloro-2-methoxyphenyl)thiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; N-(4-(5-chloro-2-methoxyphenyl)-2-methylthiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; and N-(4-(5-chloro-2-methoxyphenyl)-2-(tetrahydro-2H-pyran-4-yl)thiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide. The compounds of formula (I) are Janus kinase (JAK) inhibitors, and useful for treating cancer, polycythaemia Vera, essential thrombocytosis, myelofibrosis, chronic myelogenous leukaemia (CML), rheumatoid arthritis, inflammatory bowel syndrome, Chron’s disease, psoriasis, contact dermatitis or delayed hypersensitivity reactions.
Patent NZ-622985-A (NZ)
Title: Stabilized vitamin d formulations
Inventor: PILGAONKAR PRATIBHA S
IPC: C07C401/00
Filed: 2013-03-27
Abstract: The disclosure relates to a stable solid tablet formulation of vitamin D3 (also called cholecalciferol) comprising: (a) a tablet core comprising 5000 - 75000 IU vitamin D3, at least one lipophilic dispersant, one or more antioxidants, at least one adsorbent and one or more pharmaceutically acceptable excipients; and (b) at least one barrier coating. The lipophilic dispersants are a fatty acid, wax, a long chain monohydric alcohol, a fat or combinations thereof. The antioxidant are tocopherol, tocopherol acetate, tocopherol acid succinate, β-carotene, propyl gallate, butylated hydroxytoluene (BHT), butylated hydroxyanisole, vitamin E, ascorbic acid, sodium ascorbate, calcium ascorbate, ascorbic palmitate, 2,4,5- trihydroxybutyrophenone, 4-hydroxymethyl-2,6-di-tert-butylphenol, erythorbic acid, gum guaiac, thiodipropionic acid, dilauryl thiodipropionate, tertbutylhydroquinone or combinations thereof. The adsorbent is be mannitol, dibasic calcium phosphate, dicalcium phosphate dihydrate, calcium hydrogen phosphate dihydrate, calcium phosphate tribasic, or combinations thereof. The pharmaceutically acceptable excipient may be a diluent, binder, disintegrant, lubricant, colorant, coating agent, anti-adherent, glidant, or combinations thereof. The barrier coating comprises hydroxypropyl methylcellulose, polyvinyl alcohol, polyvinyl acetate, sodium carboxymethyl cellulose, pullulan, polyvinyl alcohol and vinyl alcoholethylene glycol copolymer; copolymer comprising methyl methacrylate and diethylaminoethyl methacrylate, poylmethacrylic acids, polymethacrylates or combinations thereof. The vitamin D3 is substantially uniformly dispersed throughout the tablet core and the formulation comprises less than about 2% by weight of total impurities after 6 months at 40°C and 75% relative humidity. The disclosure also relates to processes of preparing these formulations and the use of these formulations in the manufacture of a medicament for treating or preventing conditions associated with vitamin D3 insufficiency or deficiency, such as osteomalacia, osteoporosis, osteopenia, fibrogenesis imperfecta ossium rickets or hypocalcaemia.
Patent NZ-623338-A (NZ)
Title: Unobtrusive interface systems
Inventor: HEIDMANN DIETER
IPC: A62B9/00
Filed: 2009-03-04
Abstract: An apparatus for delivering a flow of breathable gas to a patient, comprising: a patient interface (4) configured to engage the patient’s nares; and headgear (281) headgear configured to be secured to the patient interface by a two-point connection and to maintain the patient interface in engagement with the patient’s nares. The headgear comprises a pair of elastic straps (282) extending around the back of the patient’s head. Each strap has a first end connected to the patient interface and a second end connected to the other of the pair of elastic straps. Each strap is configured to extend from the patient interface to a position at or proximal the occipital bone of the patient’s head. Each strap extends along a side of the patient’s face and above the patient’s ear.
Patent NZ-623675-A (NZ)
Title: Multiphase flow measurement
Inventor: LIAO BOHAO
IPC: G01F1/74
Filed: 2012-10-25
Abstract: A measurement section (M) of a conduit (110) receives a fluid medium containing a first fluid (G) and a second fluid (L). A first sensor device (S1 ) in the measurement section registers a first measure (m1 ) to represent a first type of physical characteristic of the fluid medium flowing through the measurement section (M). A second sensor device (S2) in the measurement section registers a second measure (m2) to represent a second type of physical characteristic of the fluid medium flowing through the measurement section (M). The second type of physical characteristic is different from the first type of physical characteristic, and thus the first and second measures (m1; m2) are independent from one another. However, both measures (m1, m2) are dependent on a flow (FG) of the first fluid (G) and a flow (FG) of the second fluid in the fluid medium. Based on the first and second measures (m1, m2), a processor (120) derives a flow (FG) of the first fluid (G) and/or a flow (F) of the second fluid (G) in the fluid medium.
Patent NZ-623690-A (NZ)
Title: Recombinant human naglu protein and uses thereof
Inventor: QUINN ANTHONY
IPC: C12N9/26
Filed: 2012-10-11
Abstract: The present disclosure provides compositions comprising an isolated mixture of recombinant human NaGlu proteins in which a substantial amount of the NaGlu proteins in the mixture has increased levels of phosphorylated mannose that confer the proteins to be efficiently internalized into human cells. The present disclosure also provides methods of producing such mixture of NaGlu proteins, vectors used in transgenesis and expression, host cells harboring such vectors, and methods of isolating and purifying the mixture of NaGlu proteins. The disclosure further provides methods of treating NaGlu associated diseases.